跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEP-2
首页
药物
PEP-2
PEP-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
uPAR selective contrast agent for magnetic resonance imaging
EP 1902734 A1
申请人: DEUTSCHES KREBSFORSCH
优先权: 2006
EP
WO
2 件公开
Pharmaceutical Compositions Comprising A Pancreatic Enzyme Preparation With Viral Infectivity Reduced Below A Significant Level And Methods Of Preparing And Using The Same
US 2014017223 A1
申请人: APTALIS PHARMA CANADA INC
优先权: 2011
CN
US
2 件公开
Clostridium perfringens bacteriophage Clo-PEP-2 and use for inhibiting Clostridium perfringens proliferation of same
US 11529406 B2
申请人: INTRON BIOTECHNOLOGY INC
优先权: 2017
CN
US
2 件公开
Pro-drug peptide with improved pharmaceutical properties
US 10889627 B2
申请人: UREKA SARL
优先权: 2017
CN
US
2 件公开
Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
US 2002164302 A1
申请人: EPSTEIN ALAN L
优先权: 2002
US
2 件公开
US 2004156824 A1
申请人: EPSTEIN ALAN L
优先权: 2004
US
Methods and compositions for modulating C5-a-mediated inflammatory responses
US 7763708 B2
申请人: INST PROTEIN SCIENCE CO LTD
优先权: 2005
US
2 件公开
PHARMACEUTICALLY ACTIVE COMPOUNDS
US 2010048921 A1
申请人: GOERNE HERBERT
优先权: 2007
US
Glial cell line-Derived Neurotrophic Factor (GDNF) fusing penetrating peptides
CN 101775072 B
申请人: SHANGWU WANG
优先权: 2008
CN
IMAGING DYES AND USE THEREOF
US 2011033883 A1
申请人: COSGRAVE LYNDA
优先权: 2008
US
Method for preparing tumor enzyme-targeted nano medicine-carrying polymer microsphere
CN 101480377 B
申请人: AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIV MED SCHOOL
优先权: 2009
CN
第 1 / 5 页
上一页
下一页
药物
反馈